1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of JAM3 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression ISO RGD:1303248 6480464 1-Naphthylisothiocyanate results in increased expression of JAM3 mRNA CTD PMID:30723492 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1303248 6480464 Tetrachlorodibenzodioxin results in decreased expression of JAM3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1303248 6480464 Tetrachlorodibenzodioxin results in increased expression of JAM3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1303248 6480464 Tetrachlorodibenzodioxin affects the expression of JAM3 mRNA CTD PMID:34747641 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1303248 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1346212 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of JAM3 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of JAM3 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:1303248 6480464 Propylthiouracil results in decreased expression of JAM3 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:1303248 6480464 acetamide results in increased expression of JAM3 mRNA CTD PMID:31881176 acetohydrazide decreases expression EXP 6480464 acetylhydrazine results in decreased expression of JAM3 mRNA CTD PMID:15282401 aconitine decreases expression ISO RGD:1303248 6480464 Aconitine results in decreased expression of JAM3 protein CTD PMID:33236894 acrylamide increases expression ISO RGD:1346212 6480464 Acrylamide results in increased expression of JAM3 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1303248 6480464 Aflatoxin B1 results in increased expression of JAM3 mRNA CTD PMID:23385219 more ... aflatoxin B1 increases methylation ISO RGD:1346212 6480464 Aflatoxin B1 results in increased methylation of JAM3 intron CTD PMID:30157460 anthracen-2-amine increases expression ISO RGD:1303248 6480464 2-anthramine results in increased expression of JAM3 mRNA CTD PMID:23038007 aristolochic acid A decreases expression ISO RGD:1346212 6480464 aristolochic acid I results in decreased expression of JAM3 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1346212 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of JAM3 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1346212 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of JAM3 mRNA CTD PMID:32525701 benzatropine multiple interactions ISO RGD:1346212 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of JAM3 protein CTD PMID:34122009 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of JAM3 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1346212 6480464 Benzo(a)pyrene results in increased methylation of JAM3 exon CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of JAM3 exon, Benzo(a)pyrene results in decreased methylation of JAM3 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1346212 6480464 Benzo(a)pyrene affects the methylation of JAM3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1346212 6480464 Benzo(a)pyrene metabolite results in increased expression of JAM3 mRNA CTD PMID:26314263 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of JAM3 mRNA CTD PMID:23735875 benzo[e]pyrene increases methylation ISO RGD:1346212 6480464 benzo(e)pyrene results in increased methylation of JAM3 intron CTD PMID:30157460 bisphenol A affects expression ISO RGD:1303248 6480464 bisphenol A affects the expression of JAM3 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of JAM3 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1346212 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of JAM3 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation ISO RGD:1303248 6480464 bisphenol A results in increased methylation of JAM3 gene CTD PMID:28505145 bisphenol F multiple interactions ISO RGD:1346212 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA CTD PMID:28628672 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of JAM3 mRNA CTD PMID:30951980 cadmium dichloride increases methylation ISO RGD:1303248 6480464 Cadmium Chloride results in increased methylation of JAM3 promoter CTD PMID:22457795 cadmium dichloride increases expression ISO RGD:1346212 6480464 Cadmium Chloride results in increased expression of JAM3 mRNA CTD PMID:25851441 clobetasol increases expression EXP 6480464 Clobetasol results in increased expression of JAM3 mRNA CTD PMID:27462272 cobalt dichloride increases expression ISO RGD:1346212 6480464 cobaltous chloride results in increased expression of JAM3 mRNA CTD PMID:26314263 Cuprizon decreases expression ISO RGD:1303248 6480464 Cuprizone results in decreased expression of JAM3 mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO RGD:1346212 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of JAM3 protein CTD PMID:34122009 dexamethasone increases expression ISO RGD:1346212 6480464 Dexamethasone results in increased expression of JAM3 mRNA CTD PMID:12782123 dexamethasone multiple interactions ISO RGD:1346212 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA CTD PMID:28628672 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM3 mRNA CTD PMID:29950665 diethyl maleate decreases expression ISO RGD:1303248 6480464 diethyl maleate results in decreased expression of JAM3 mRNA CTD PMID:21161181 endosulfan decreases expression ISO RGD:1303248 6480464 Endosulfan results in decreased expression of JAM3 mRNA CTD PMID:29391264 endosulfan increases expression ISO RGD:1303248 6480464 Endosulfan results in increased expression of JAM3 mRNA CTD PMID:31464424 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of JAM3 mRNA CTD PMID:35436446 fipronil increases expression ISO RGD:1303248 6480464 fipronil results in increased expression of JAM3 mRNA CTD PMID:31881178 fonofos increases methylation ISO RGD:1346212 6480464 Fonofos results in increased methylation of JAM3 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:1346212 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of JAM3 gene CTD PMID:31601247 Heliotrine increases expression ISO RGD:1303248 6480464 heliotrine results in increased expression of JAM3 mRNA CTD PMID:32419051 indometacin multiple interactions ISO RGD:1346212 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA CTD PMID:28628672 Lasiocarpine increases expression ISO RGD:1303248 6480464 lasiocarpine results in increased expression of JAM3 mRNA CTD PMID:32419051 lead(0) affects expression ISO RGD:1346212 6480464 Lead affects the expression of JAM3 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1346212 6480464 Lead affects the expression of JAM3 mRNA CTD PMID:28903495 methapyrilene increases methylation ISO RGD:1346212 6480464 Methapyrilene results in increased methylation of JAM3 intron CTD PMID:30157460 methylmercury(1+) increases expression ISO RGD:1346212 6480464 methylmercury II results in increased expression of JAM3 mRNA CTD PMID:26314263 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1346212 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of JAM3 gene CTD PMID:30521419 ochratoxin A increases expression ISO RGD:1346212 6480464 ochratoxin A metabolite results in increased expression of JAM3 mRNA, ochratoxin A results in increased expression of JAM3 mRNA CTD PMID:26314263 oxaliplatin increases expression ISO RGD:1303248 6480464 oxaliplatin results in increased expression of JAM3 mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:1303248 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of JAM3 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1346212 6480464 Ozone results in increased expression of JAM3 mRNA CTD PMID:31476115 ozone increases expression ISO RGD:1303248 6480464 Ozone results in increased expression of JAM3 mRNA CTD PMID:35737395 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of JAM3 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1303248 6480464 Acetaminophen results in increased expression of JAM3 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1346212 6480464 Parathion results in increased methylation of JAM3 promoter CTD PMID:22847954 perfluorooctanoic acid decreases expression ISO RGD:1346212 6480464 perfluorooctanoic acid results in decreased expression of JAM3 mRNA CTD PMID:23146750 senecionine increases expression ISO RGD:1303248 6480464 senecionine results in increased expression of JAM3 mRNA CTD PMID:32419051 sodium arsenate multiple interactions ISO RGD:1346212 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of JAM3 mRNA CTD PMID:32525701 sodium arsenite decreases methylation EXP 6480464 sodium arsenite results in decreased methylation of JAM3 gene CTD PMID:32068019 T-2 toxin decreases expression ISO RGD:1346212 6480464 T-2 Toxin results in decreased expression of JAM3 mRNA CTD PMID:31863870 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of JAM3 mRNA CTD PMID:17555576 terbufos increases methylation ISO RGD:1346212 6480464 terbufos results in increased methylation of JAM3 promoter CTD PMID:22847954 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of JAM3 mRNA CTD PMID:14729362 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of JAM3 mRNA CTD PMID:17484886 thioacetamide affects expression ISO RGD:1303248 6480464 Thioacetamide affects the expression of JAM3 mRNA CTD PMID:34492290 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM3 mRNA CTD PMID:29950665 topotecan increases expression ISO RGD:1303248 6480464 Topotecan results in increased expression of JAM3 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1303248 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of JAM3 mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:1346212 6480464 tributyltin results in increased expression of JAM3 mRNA CTD PMID:26314263 Tributyltin oxide increases expression ISO RGD:1346212 6480464 bis(tri-n-butyltin)oxide results in increased expression of JAM3 mRNA CTD PMID:26314263 trichloroethene increases expression ISO RGD:1303248 6480464 Trichloroethylene results in increased expression of JAM3 mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:1346212 6480464 Triclosan results in decreased expression of JAM3 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of JAM3 mRNA CTD PMID:19042947 triptonide increases expression EXP 6480464 triptonide results in increased expression of JAM3 mRNA CTD PMID:33045310 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of JAM3 mRNA CTD PMID:17127020 urethane increases expression ISO RGD:1346212 6480464 Urethane results in increased expression of JAM3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1346212 6480464 Valproic Acid affects the expression of JAM3 mRNA CTD PMID:25979313 vinclozolin affects expression ISO RGD:1303248 6480464 vinclozolin affects the expression of JAM3 mRNA CTD PMID:23034163